South Dakota Investment Council Exelixis, Inc. Transaction History

South Dakota Investment Council

$5.12 Billion
Q3 2024

A detailed history of South Dakota Investment Council transactions in Exelixis, Inc. stock. As of the latest transaction made, South Dakota Investment Council holds 69,987 shares of EXEL stock, worth $2.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

69,987

Previous 69,987 -0.0%

Holding current value

$2.36 Million

Previous $1.57 Million 15.45%

% of portfolio

0.04%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$20.34 - $23.73 $2.22 Million - $2.59 Million	-109,071 Reduced 60.91%	69,987 $1.57 Million
Q1 2024 May 02, 2024	SELL	$20.17 - $23.93 $94,799 - $112,471	-4,700 Reduced 2.56%	179,058 $4.25 Million
Q3 2023 Nov 07, 2023	SELL	$19.04 - $22.74 $66,640 - $79,590	-3,500 Reduced 1.87%	183,758 $4.02 Million
Q2 2023 Aug 10, 2023	BUY	$18.17 - $20.48 $38,084 - $42,926	2,096 Added 1.13%	187,258 $3.58 Million
Q1 2023 May 10, 2023	BUY	$16.3 - $19.41 $489,000 - $582,300	30,000 Added 19.33%	185,162 $3.59 Million
Q4 2022 Feb 07, 2023	BUY	$14.96 - $17.39 $435,336 - $506,049	29,100 Added 23.08%	155,162 $2.49 Million
Q2 2022 Aug 11, 2022	SELL	$17.44 - $23.16 $3.88 Million - $5.16 Million	-222,604 Reduced 63.84%	126,062 $2.63 Million
Q1 2022 May 10, 2022	SELL	$17.03 - $22.67 $3.66 Million - $4.87 Million	-214,866 Reduced 38.13%	348,666 $7.9 Million
Q3 2021 Nov 09, 2021	BUY	$16.3 - $21.14 $1.59 Million - $2.06 Million	97,600 Added 20.95%	563,532 $11.9 Million
Q2 2021 Aug 11, 2021	SELL	$17.95 - $25.56 $169,268 - $241,030	-9,430 Reduced 1.98%	465,932 $8.49 Million
Q1 2021 May 13, 2021	BUY	$20.53 - $25.22 $800,731 - $983,655	39,003 Added 8.94%	475,362 $10.7 Million
Q3 2020 Nov 06, 2020	SELL	$20.67 - $26.94 $168,047 - $219,022	-8,130 Reduced 1.83%	436,359 $10.7 Million
Q2 2020 Aug 13, 2020	SELL	$16.46 - $27.42 $475,743 - $792,520	-28,903 Reduced 6.11%	444,489 $10.6 Million
Q1 2020 May 11, 2020	BUY	$14.46 - $21.8 $263,880 - $397,828	18,249 Added 4.01%	473,392 $8.15 Million
Q4 2019 Feb 11, 2020	BUY	$15.15 - $18.89 $1.93 Million - $2.4 Million	127,213 Added 38.79%	455,143 $8.02 Million
Q3 2019 Nov 13, 2019	BUY	$17.68 - $22.65 $1.97 Million - $2.52 Million	111,437 Added 51.47%	327,930 $5.8 Million
Q2 2019 Aug 13, 2019	BUY	$18.93 - $24.75 $1.15 Million - $1.5 Million	60,693 Added 38.96%	216,493 $4.63 Million
Q4 2018 Feb 06, 2019	BUY	$13.65 - $21.8 $629,265 - $1 Million	46,100 Added 42.02%	155,800 $3.07 Million
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $1.74 Million - $2.46 Million	109,700 New	109,700 $1.94 Million

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.8B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.

Account

South Dakota Investment Council Exelixis, Inc. Transaction History